Actinium Pharmaceuticals, Inc.
ATNM· NYSE
ATNMActinium Pharmaceuticals, Inc.
Filed Nov 3, 2017 · 10-Q · 34 days after period end · 0001213900-17-011347
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Net Income | -$6.32M | -$6.60M | -$3.95M | -$6.08M |
| EPS Diluted | -$0.09 | -$0.14 | -$0.10 | -$0.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Actinium Pharmaceuticals, Inc. · CIK 1388320 · Engraved from SEC EDGAR
ended Sep 30, 2017 · filed Nov 3, 2017 · 34 d after period end
